Concepedia

The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma

Imène Hamaidi, Catherine Coquard, Sabrina Danilin, Valérian Dormoy, C Béraud, Sylvie Rothhut, Mariette Barthelmebs, Nadia Benkirane-Jessel, Véronique Lindner, Hervé Lang,

Oncogene · 2018 · 28 citations · 40 references

DOIFull text

Open access

Concepts

References

40

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

, , +16

Clonogenic assay of cells in vitro

Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations

, , +8

Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study

Bernard Escudier, Camillo Porta, Petri Bono et al. · Journal of Clinical Oncology · 2014 · 439 citations · Full text

, , +15

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.

Norihiro Sato, Noriyoshi Fukushima, Anirban Maitra et al. · PubMed · 2003 · 338 citations · Full text

, , +14

Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.

Bhaskar Kallakury, Shridevi Karikehalli, A Haholu et al. · PubMed · 2001 · 283 citations

, , +15